“Progressive and Sustained Disease Control in Patients With Atopic Dermatitis (AD) Aged 12–17 Years Treated With Tralokinumab for 52 Weeks”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s377. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2680.